CTRI/2020/08/027305已完成4 期
Comparative evaluation of the effectiveness of Stevia extract used as powder versus Amoxicillin trihydrate powder in surgical extraction of mandibular third molar among 18-45-year-old adults - A split mouth Randomized controlled trial.â??
Dr Nidhi Pandey0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients aged between 18-45 years
- •2. Patients of both sexes will be included.
- •3. Patients with good physical and mental status.
- •4. Patient requiring bilateral surgical extraction of mandibular third molars.
- •5. Absence of any infection (pericoronitis) prior to the surgery.
- •6. Patients with non-palpable submandibular lymph nodes.
- •7. Patients who were not on antibiotics for last 7 days.
- •8. Patients consenting for the study
排除标准
- •1 Patients with a known medical history
- •2 Febrile patients with an active infection elsewhere
- •3 Patients with an immune-compromised state.
- •4 Patients with a known drug and /or food allergy
- •5 A recent use of antimicrobial drug (in the last 7 days).
- •6 Uncooperative patients, mentally retarded patients.
- •7 Pregnant or lactating mothers.
研究者
相似试验
招募中
不适用
To evaluate the effectiveness of teeth cleaning alone or with laser for treatment of gum disease who have high blood sugarCTRI/2022/11/047613DR CHING NUN SIAM
已完成
不适用
A STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ACCELERATED PHASE-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-073-00OVARTIS BIOSCIENSES PERU S.A.,
尚未招募
3 期
Examining if Strophanthus Q Can Help Improve Heart Function in Coronary Artery DiseaseCTRI/2024/03/063641il
尚未招募
2 期
A clinical trial to study the effect of two drugs saptaparna bark and chirabilva bark in patients with Kitibha kushta (psoriasis)CTRI/2022/10/046834Dr.Vinoda Y Sidaraddi
已完成
不适用
A STUDY TO DETERMINE THE SAFETY AND EFFICACY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA THAT ARE HEMATOLOGICALLY OR CYGOGENICALLY RESISTANT OR REFRACTORY OR INTOLERANT TO THE ALPHA INTERFERO-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-004-01OVARTIS BIOSCIENSES PERU S.A.,